title: Phase II study of dose-intense chemotherapy with sequential topoisomerase-targeting regimens with irinotecan/oxaliplatin followed by etoposide/carboplatin in chemotherapy naive patients with extensive small cell lung cancer.
authors.affiliation: Comprehensive Cancer Center, Division of Hematology-Oncology, University of Alabama at Birmingham, 1802 Sixth Avenue South, NPCC 2540, Birmingham, AL 35294-3300, United States.
authors.forename: Joanne
authors.initials: J
authors.lastname: Rossman
authors.forename: Vishnu
authors.initials: V
authors.lastname: Reddy
authors.forename: Alan
authors.initials: A
authors.lastname: Cantor
authors.forename: Debi
authors.initials: D
authors.lastname: Miley
authors.forename: Francisco
authors.initials: F
authors.lastname: Robert